Abstract
Autozygosity is associated with rare Mendelian disorders and clinically-relevant quantitative traits. We investigated associations between FROH (fraction of the genome in runs of homozygosity) and common diseases in Genes & Health (N=23,978 British South Asians), UK Biobank (N=397,184), and 23andMe, Inc. We show that restricting analysis to offspring of first cousins is an effective way of removing confounding due to social/environmental correlates of FROH. Within this group in G&H+UK Biobank, we found experiment-wide significant associations between FROH and twelve common diseases. We replicated the associations with type 2 diabetes (T2D) and post-traumatic stress disorder via between-sibling analysis in 23andMe (median N=480,282). We estimated that autozygosity due to consanguinity accounts for 5-18% of T2D cases amongst British Pakistanis. Our work highlights the possibility of widespread non-additive effects on common diseases and has important implications for global populations with high rates of consanguinity.
Competing Interest Statement
J.O. and members of the 23andMe Research Team are employed by and hold stock or stock options in 23andMe, Inc. Other authors report no disclosures.
Funding Statement
Authors from the Wellcome Sanger Institute are supported by Wellcome grant 220540/Z/20/A, 'Wellcome Sanger Institute Quinquennial Review 2021-2026'. Genes & Health is/has recently been core-funded by Wellcome (WT102627, WT210561), the Medical Research Council (UK) (M009017, MR/X009777/1), Higher Education Funding Council for England Catalyst, Barts Charity (845/1796), Health Data Research UK (for London substantive site), and research delivery support from the NHS National Institute for Health Research Clinical Research Network (North Thames). Genes & Health is/has recently been funded by Alnylam Pharmaceuticals, Genomics PLC; and a Life Sciences Industry Consortium of Astra Zeneca PLC, Bristol-Myers Squibb Company, GlaxoSmithKline Research and Development Limited, Maze Therapeutics Inc, Merck Sharp & Dohme LLC, Novo Nordisk A/S, Pfizer Inc, Takeda Development Centre Americas Inc. Additional funding for this work was awarded by the Medical Research Council (MR/S027297/1).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The London South East NRES Committee of the Health Research Authority gave ethical approval for the G&H work (14/LO/1240, dated 16 September 2014). The North West Multi-centre Research Ethics Committee (MREC) gave ethical approval for UK Biobank. Ethical & Independent Review Services of Salus IRB gave ethical approval for 23andMe research.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
G&H data are available for analysis within a secure Trusted Research Environment) upon application to the G&H executive, as described here https://www.genesandhealth.org/research/scientists-using-genes-health-scientific-research. UK Biobank data are also available upon application (https://www.ukbiobank.ac.uk/enable-your-research/apply-for-access).
